Avanza Bank Holding AB (0NUK)
London Exchange · UK · prices in SEK · close of 20 Oct 2026
Key indicators
| Last close | SEK 357.60 |
|---|---|
| 52-week range | 318.50 – 407.50 |
| Return, 1 month / 3 months | −9.9% / −9.0% |
| Return, 1 year / 3 years | −2.9% / +103.0% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 27.4% |
| Worst drawdown (1 year) | -20.4% |
| Average daily value traded | 17.51M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Avanza Bank Holding AB is a Swedish online bank that serves private individuals with savings and investing services. It offers brokerage accounts for trading securities, a broad range of mutual funds, and pension savings products, along with related banking services such as accounts and cards. Customers manage their savings through digital channels, and the company is based in Stockholm, Sweden, where it focuses on personal finance for retail clients.
Avanza Bank Holding AB trades under the code 0NUK on the London Exchange in UK, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Avanza Bank Holding AB (0NUK) trades on the London Exchange in UK. It last closed at SEK 357.60 on 20 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 1,342 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.9% and over the last three months it fell 9.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.1% | ||
| From 52-week high | -12.2% | ||
| Momentum | 41 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -9.0% | ||
| 6-month return | -3.8% | ||
| 12-month return, skipping the last month | 7.7% | ||
| Stability (higher is calmer) | 70 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.4% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 17.51M SEK | ||
| Zero-volume days | 3.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −5.8% |
|---|---|
| 1 month | −9.9% |
| 3 months | −9.0% |
| 6 months | −3.8% |
| 1 year | −2.9% |
| 3 years | +103.0% |
| 5 years | +24.9% |
Signals
| 50-day / 200-day average | 388.84 / 365.22 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 12.17 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Apr 2025 | SEK 11.7500 |
| 12 Apr 2024 | SEK 11.5000 |
| 31 Mar 2023 | SEK 7.5000 |
| 1 Apr 2022 | SEK 9.2000 |
| 17 Nov 2021 | SEK 2.9500 |
| 31 Mar 2021 | SEK 0.8500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.